AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Pathways Mediating Impaired Postural Control in Parkinson's Disease

Recruitingn/aAges 45 Years - 80 YearsAllUniversity of Minnesota
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

The purpose of this project is to use transcranial magnetic stimulation (TMS) to explore the state of excitability of corticocortical and corticofugal (cortex to spinal cord, cortex to brainstem to spinal cord) pathways that project to muscles that control the legs and trunk in people with Parkinson's disease. The outcome variables will be further analyzed to understand their relationship to quantitative measures of postural instability and gait dysfunction. As such, the project can be classified as basic physiologic research. The protocol is not designed to determine if measures of corticocortical or corticofugal excitability can be used as a biomarker to predict disease progression.

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: Participants with Parkinson's disease * Diagnosis of idiopathic PD or dystonia as determined by a movement disorders neurologist in accordance with the UK Society Brain Bank diagnostic criteria. * Age 45-80 years. * Able to ambulate independently without the use of an assistive device (e.g. cane) for 50 meters. Healthy Older Adults (Control participants) * Age 45-80 years (this group will be age and sex-matched to the PD group) * Able to ambulate independently without the use of an assistive device (cane or walker) Healthy Young Adults * Age 21-44 years (this group will be age and sex-matched to the PD group) * Able to ambulate independently without the use of an assistive device (cane or walker) Exclusion Criteria: * Subjects who describe a history of a frequent vasovagal syncope (fainting) in response to blood, emotional stress, or sensory triggers. * Subjects who are on anti-coagulant medications. * Any musculoskeletal disorder that affects the ability to stand. * History of seizures, epilepsy, stroke, multiple sclerosis, or traumatic brain injury. * Intracranial metallic or magnetic devices. * Pacemaker or any implanted device. * History of surgery on blood vessels, brain or heart. * Unexplained, recurring headaches or concussion within the last six months. * Moderate to severe hearing impairment. * Subjects who are pregnant. * Dementia diagnosis * Other significant neurological disorders that may affect participation or performance in the study * Implanted deep brain stimulator or other neurosurgeries to treat PD.
๐Ÿ’Š

What it tests

  • Not listed
๐Ÿ“

Where

1 site
University of Minnesota
Minneapolis, United States
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy